Molecular characterization and assessment of therapeutic outcomes for inherited cutaneous disorders requires faithful preclinical models. In this study we report the establishment of two different skin-humanized pachyonychia congenita (PC) model systems, based on permanent engraftment of bioengineered skin equivalents generated from patient skin cells onto immunodeficient mice. Using keratinocytes and fibroblasts isolated from unaffected skin biopsies of two PC patients carrying the p.Asn171Lys mutation of the keratin 6a gene (KRT6A), we were able to regenerate PC-derived human skin that appeared phenotypically normal, but developed sustained PC features after the use of an acute hyperproliferative stimulus (i.e., tape stripping). In contra...
Cutaneous wound-healing disorders are a major health problem that requires the development of innova...
RNA interference offers a novel approach for treating genetic disorders including the rare monogenic...
Keratin 16 (KRT16 in human, Krt16 in mouse), a type I intermediate filament protein, is constitutive...
Molecular characterization and assessment of therapeutic outcomes for inherited cutaneous disorders ...
The similarities between the human and mouse genomes often allow researchers to make accurate predic...
Pachyonychia congenita (PC) is an autosomal dominant genodermatosis caused by heterozygous mutations...
Pachyonychia congenita (PC) is an autosomal dominant genodermatosis caused by heterozygous mutations...
Pachyonychia congenita (PC) is an autosomal-dominant keratin disorder where the most painful, debili...
Pachyonychia congenita (PC) is an autosomal-dominant keratin disorder where the most painful, debili...
Palmoplantar keratoderma is a hallmark of pachyonychia congenita (PC) and focal non-epidermolytic pa...
Ongoing progress in the field of regenerative medicine, in combination with the development of tissu...
In 1994, the molecular basis of pachyonychia congenita (PC) was elucidated. Four keratin genes are a...
The field of science and medicine has experienced a flood of data and technology associated with the...
Pachyonychia congenita (PC) is a rare autosomal dominant skin disorder characterized predominantly b...
Pachyonychia congenita (PC) is a rare autosomal dominant skin disorder characterized predominantly b...
Cutaneous wound-healing disorders are a major health problem that requires the development of innova...
RNA interference offers a novel approach for treating genetic disorders including the rare monogenic...
Keratin 16 (KRT16 in human, Krt16 in mouse), a type I intermediate filament protein, is constitutive...
Molecular characterization and assessment of therapeutic outcomes for inherited cutaneous disorders ...
The similarities between the human and mouse genomes often allow researchers to make accurate predic...
Pachyonychia congenita (PC) is an autosomal dominant genodermatosis caused by heterozygous mutations...
Pachyonychia congenita (PC) is an autosomal dominant genodermatosis caused by heterozygous mutations...
Pachyonychia congenita (PC) is an autosomal-dominant keratin disorder where the most painful, debili...
Pachyonychia congenita (PC) is an autosomal-dominant keratin disorder where the most painful, debili...
Palmoplantar keratoderma is a hallmark of pachyonychia congenita (PC) and focal non-epidermolytic pa...
Ongoing progress in the field of regenerative medicine, in combination with the development of tissu...
In 1994, the molecular basis of pachyonychia congenita (PC) was elucidated. Four keratin genes are a...
The field of science and medicine has experienced a flood of data and technology associated with the...
Pachyonychia congenita (PC) is a rare autosomal dominant skin disorder characterized predominantly b...
Pachyonychia congenita (PC) is a rare autosomal dominant skin disorder characterized predominantly b...
Cutaneous wound-healing disorders are a major health problem that requires the development of innova...
RNA interference offers a novel approach for treating genetic disorders including the rare monogenic...
Keratin 16 (KRT16 in human, Krt16 in mouse), a type I intermediate filament protein, is constitutive...